Jushi Holdings (JUSHF) Free Cash Flow (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Free Cash Flow of -$3.1 million for Q2 2026, up 48.75% year-over-year from -$2.1 million in Q2 2025, and down 155.59% quarter-over-quarter from $5.6 million in Q1 2026.
Jushi Holdings (JUSHF) Free Cash Flow (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Free Cash Flow for 6 consecutive years, with -$3.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow rose 48.75% year-over-year to -$3.1 million; the TTM figure through Jun 2026 stood at $6.7 million (up 64.69% YoY), while the FY2025 annual figure was $1.6 million, down 90.3% from the prior year.
- Free Cash Flow declined to -$3.1 million in Q2 2026 per JUSHF's latest filing, from $5.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $5.6 million in Q1 2026 and bottomed at -$38.8 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$4.0 million across 5 years, with a median of $715500.0 in 2023.
- Annual changes were most pronounced in 2024 — Free Cash Flow jumped 639.17% — and 2025, when it sank 224.48%.
- Jushi Holdings' Free Cash Flow stood at -$2.9 million in 2022, then soared by 175.0% to $2.2 million in 2023, then surged by 131.52% to $5.0 million in 2024, then plunged by 40.48% to $3.0 million in 2025, then plunged by 204.62% to -$3.1 million in 2026.
- Business Quant data shows JUSHF's Free Cash Flow at -$3.1 million in Q2 2026, $5.6 million in Q1 2026, and $3.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 307.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 538.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.14 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 205.60 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 329.00 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 128.60 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 244.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.10 Mn |
| Jun 30, 2026 | -3.10 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | -6.05 Mn |
| Jun 30, 2025 | -6.05 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Dec 31, 2024 | 4.98 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Jun 30, 2024 | 4.86 Mn |
| Mar 31, 2024 | 5.42 Mn |
| Mar 31, 2024 | 5.42 Mn |